The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and toxicity of FOLFOX-4 as a second-line chemotherapy in locally advanced unresectable and metastatic carcinoma gall bladder: A prospective observational study.
Chandragouda Dodagoudar
No relevant relationships to disclose
Anupam Mahanta
No relevant relationships to disclose
Vikas Goswami
No relevant relationships to disclose
Varun Goel
No relevant relationships to disclose
Dinesh C Doval
No relevant relationships to disclose
Vineet Talwar
No relevant relationships to disclose
Ullas Batra
No relevant relationships to disclose
Sajjan Singh
No relevant relationships to disclose
Deepika Chauhan
No relevant relationships to disclose